Elsevier

JACC: Heart Failure

Volume 9, Issue 12, December 2021, Pages 890-903
JACC: Heart Failure

Mini-focus Issue: Acute Decompensated Heart Failure
Clinical Research
Association of Early Blood Pressure Decrease and Renal Function With Prognosis in Acute Heart Failure

https://doi.org/10.1016/j.jchf.2021.07.001Get rights and content
Under an Elsevier user license
open archive

Abstract

Objectives

The aim of this study was to investigate the association between systolic blood pressure (SBP) drop, worsening renal function (WRF), and prognosis in patients with acute heart failure (AHF).

Background

A large drop in SBP early after hospital admission for AHF might be associated with increased risk for WRF and prognosis. However, there is a paucity of data regarding the interaction between WRF and a drop in SBP on clinical outcomes.

Methods

A post hoc analysis among 6,544 patients with AHF enrolled in the RELAX-AHF-2 (Relaxin in Acute Heart Failure-2) trial was performed. Blood pressure was uniformly and repetitively measured. Peak SBP drop was defined as the difference between baseline SBP and lowest SBP documented during the first 48 hours. WRF was defined by an increase in serum creatinine of ≥0.3 mg/dL from baseline to day 5.

Results

Peak SBP drop was independently associated with a higher risk for WRF (HR: 1.11 per 10 mm Hg SBP drop; P < 0.001), 5-day worsening heart failure (HR: 1.12 per 10 mm Hg SBP drop; P = 0.006), and 180-day cardiovascular death (HR: 1.09 per 10 mm Hg SBP drop; P = 0.026) after adjustment for potential confounders including baseline SBP. There was no interaction between the prognostic value of early SBP drop according to the presence or absence of WRF.

Conclusions

In patients hospitalized for AHF, a greater early drop in SBP was associated with a higher incidence of WRF, worsening heart failure, and an increased risk for 180-day cardiovascular death. However, the association between SBP drop and prognosis was not influenced by WRF. (Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF [RELAX-AHF-2]; NCT01870778)

Key Words

acute heart failure
blood pressure
renal dysfunction

Abbreviations and Acronyms

AHF
acute heart failure
BNP
brain natriuretic peptide
CV
cardiovascular
NT-proBNP
N-terminal pro–brain natriuretic peptide
SBP
systolic blood pressure
WHF
worsening heart failure
WRF
worsening renal function

Cited by (0)

Anthony DeMaria, MD, served as the Guest Editor for this paper.

The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.